Cargando…
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Many commonly used drugs were evaluated as repurposed treatment options since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has been controversial in this regard. In this systematic review, we assessed the effect of these medications as adjunctive therapy i...
Autores principales: | Khalaji, Amirmohammad, Behnoush, Amir Hossein, Alilou, Sanam, Rezaee, Malihe, Peiman, Soheil, Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165571/ https://www.ncbi.nlm.nih.gov/pubmed/37158917 http://dx.doi.org/10.1186/s12944-023-01828-w |
Ejemplares similares
-
Aspirin and P2Y12 inhibitors in treating COVID-19
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis
por: Ghondaghsaz, Elina, et al.
Publicado: (2023) -
Chemerin levels in chronic kidney disease: A systematic review and meta-analysis
por: Behnoush, Amir Hossein, et al.
Publicado: (2023) -
Endocan in prediabetes, diabetes, and diabetes-related complications: a systematic review and meta-analysis
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
Machine learning‐based prediction of 1‐year mortality in hypertensive patients undergoing coronary revascularization surgery
por: Behnoush, Amir Hossein, et al.
Publicado: (2023)